|
Vorotylov A.A., Mikhailova Z.D.
Features of kidney damage in metabolic syndrome
|
№2 / 2023
|
|
Mikhailova L.V., Shupina M.I., Safonova V.S., Butova V.V., Sheremet V.V.
The functional state of the kidneys and albuminuria in individuals with cardiovascular risk factors
|
№1 / 2022
|
|
A.Yu. Nikolayev
Drug-induced hypertension in the clinic of internal diseases
|
№2 / 2017
|
|
Ja.F. Zverev, V.M. Brjuhanov
Modern view on mechanisms of uric acid nephrolithiasis
|
№5-6 / 2015
|
|
B.G. Iskenderov, O.N. Sisina
Acute kidney injury and its prognostic value for patients with metabolic syndrome and intact glomerular filtration who underwent coronary artery bypass grafting
|
№1 / 2015
|
|
V.V. Fomin
Urinary tract infections in diabetes mellitus and metabolic syndrome: role of combined phytotherapy
|
№4 / 2013
|
|
N.V. Zagorodnikova, O.N. Rzhevskaya, K.E. Lazareva, N.V. Shmarina, A.V. Pinchuk
Prevalence of metabolic syndrome in early perioperative period after renal tranplantation
|
№3 / 2013
|
|
I.A. Tiuzikov, A.P. Ivanov
Interdisciplinary approach to diagnosis of diseases of solitary kidney in men
|
№2 / 2013
|
|
E.M. Shilov, E.I. Levankovskaya, M.S. Novikova
New approaches in treatment of chronic kidney disease in metabolic syndrome
|
№2 / 2012
|
|
E.A. Saginova, M.M. Severova, M.G. Galliamov, N.V. Ermakov, A.V. Rodina, V.V. Fomin, N.A. Moukhin
Clinical sighnificance of adiponectinemia in development of target organ-damage in metabolic syndrome, associated with non-alcoholic fatty liver disease
|
№6 / 2011
|
|
M.M. Severova, E.A. Saginova, M.G. Gallyamov, N.V. Ermakov, A.V. Rodina, M.V. Severov, V.V. Fomin, N.A. Moukhin
Association of leptinemia and adiponectinemia with chronic kidney disease in patients with metabolic syndrome and non-alcoholic fatty liver disease
|
№1 / 2011
|
|
V.V. Fomin, E.A. Saginova
Aliskiren – direct renin inhibitor in treatment of cardio-renal syndrome in patients with metabolic syndrome and obesity
|
№4 / 2010
|
Русский
